Anthrax-Related MMWRs
On This Page
Anthrax and Animal Products
Bioterrorism
- Notice to Readers: Protecting Building Environments from Airborne Chemical, Biologic, or Radiologic Attacks
- Update: Investigation of Bioterrorism-Related Anthrax — Connecticut, 2001
- Update: Investigation of Bioterrorism-Related Inhalational Anthrax —Connecticut, 2001
- Update: Investigation of Bioterrorism-Related Anthrax, 2001
- Investigation of Bioterrorism-Related Anthrax & Adverse Events from Antimicrobial Prophylaxis
- Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
- Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy, October 2001
- Recognition of Illness Associated with the Intentional Release of a Biologic Agent
Diagnosis
- Notice to Readers: Use of Onsite Technologies for Rapidly Assessing Environmental Bacillus anthracis Contamination on Surfaces in Buildings
- Notice to Readers: Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax
- Recognition of Illness Associated with the Intentional Release of a Biologic Agent
Guidelines and Recommendations
- Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident: CDC Recommendations (2015) pdf icon[PDF – 1.24MB]
- Medical Examiners, Coroners, and Biologic Terrorism: A Guidebook for Surveillance and Case Management
- Notice to Readers: Interim Guidelines for Investigation of and Response to Bacillus Anthracis Exposures
- Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
- Notice to Readers: Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis
- Notice to Readers: Interim Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites in which Mail is Handled or Processed
- Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy, October 2001
- Use of Anthrax Vaccine in the United States, ACIP Recommendations
- Update: Interim Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children with Anthrax
Pregnancy
- Notice to Readers: Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis
- Update: Interim Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children with Anthrax
Prophylaxis
- Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
- Notice to Readers: Status of U.S. Department of Defense Preliminary Evaluation of the Association of Anthrax Vaccination and Congenital Anomalies
- Use of Anthrax Vaccine in the United States, ACIP Recommendations
- Surveillance for Adverse Events Associated with Anthrax Vaccination – U.S. Department of Defense, 1998-2000
- Notice to Readers: Evaluation of Postexposure Antibiotic Prophylaxis to Prevent Anthrax
Worker Safety
- Follow-Up of Deaths Among U.S. Postal Service Workers Potentially Exposed to Bacillus anthracis—District of Columbia, 2001–2002
- Adverse Events Associated with Anthrax Prophylaxis Among Postal Employees — New Jersey, New York City, & the District of Columbia Metropolitan Area, 2001
- Notice to Readers: Occupational Health Guidelines for Remediation Workers at Bacillus anthracis-Contaminated Sites—United States, 2001–2002
- Notice to Readers: Interim Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites in which Mail is Handled or Processed
Page last reviewed: November 20, 2020